Company Neuronetics, Inc.

Equities

STIM

US64131A1051

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 03:29:10 2024-04-16 pm EDT 5-day change 1st Jan Change
4.09 USD -1.68% Intraday chart for Neuronetics, Inc. -6.55% +42.76%

Business Summary

Neuronetics, Inc. is a commercial-stage medical technology company. The Company is focused on designing, developing and marketing products for patients who suffer from neurohealth disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The NeuroStar Advanced Therapy System is used to treat adult patients with major depressive disorder (MDD). The Company intends to continue to pursue development of its NeuroStar Advanced Therapy System for additional indications. The Company sells its NeuroStar Advanced Therapy System and recurring treatment sessions in the United States. Its primary focus is on selling to psychiatrists, with primary care physicians and pain management specialists.

Number of employees: 203

Sales per Business

USD in Million2022Weight2023Weight Delta
Treatment Sessions
72.4 %
45 69.7 % 52 72.4 % +13.69%
NeuroStar Advanced Therapy System
24.0 %
17 26.7 % 17 24.0 % -1.71%
Other
3.7 %
2 3.7 % 3 3.7 % +9.21%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
97.2 %
63 97.2 % 69 97.2 % +9.35%
International
2.8 %
2 2.8 % 2 2.8 % +11.78%

Managers

Managers TitleAgeSince
Chief Executive Officer 66 20-07-13
Director of Finance/CFO 60 -
Chief Tech/Sci/R&D Officer - 21-02-28
Compliance Officer 51 20-01-20
Sales & Marketing - 23-04-30
Comptroller/Controller/Auditor - -
Corporate Officer/Principal - 20-10-04
Corporate Officer/Principal - 21-05-31

Members of the board

Members of the board TitleAgeSince
Chairman 69 21-03-31
Director/Board Member 63 19-09-30
Director/Board Member 67 05-04-30
Director/Board Member 63 20-03-31
Director/Board Member 65 17-06-30
Chief Executive Officer 66 20-07-13
Director/Board Member 60 22-12-31
Director/Board Member 47 21-08-01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 29,974,617 27,771,389 ( 92.65 %) 0 92.65 %

Shareholders

NameEquities%Valuation
Cannell Capital LLC
9.307 %
2,769,268 9.307 % 13 M $
Archon Capital Management LLC
8.526 %
2,537,097 8.526 % 12 M $
Divisadero Street Capital Management LP
5.173 %
1,539,382 5.173 % 7 M $
Balyasny Asset Management LP
4.764 %
1,417,722 4.764 % 7 M $
1,372,278 4.612 % 7 M $
Vanguard Global Advisers LLC
4.547 %
1,353,144 4.547 % 6 M $
1,126,484 3.786 % 5 M $
Kent Lake Capital LLC
3.751 %
1,116,041 3.751 % 5 M $
First Eagle Investment Management LLC
2.608 %
776,009 2.608 % 4 M $
Parian Global Management LP
2.555 %
760,410 2.555 % 4 M $

Company contact information

Neuronetics, Inc.

3222 Phoenixville Pike

19355, Malvern

+610 640 4202

http://www.neuronetics.com
address Neuronetics, Inc.(STIM)
  1. Stock Market
  2. Equities
  3. STIM Stock
  4. Company Neuronetics, Inc.